These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 23537503)

  • 1. Nanocarrier systems for oral drug delivery: do we really need them?
    Bernkop-Schnürch A
    Eur J Pharm Sci; 2013 May; 49(2):272-7. PubMed ID: 23537503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprint of: Nanocarrier systems for oral drug delivery: do we really need them?
    Bernkop-Schnürch A
    Eur J Pharm Sci; 2013 Sep; 50(1):2-7. PubMed ID: 23816602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanocarriers for oral drug delivery.
    Zhang L; Wang S; Zhang M; Sun J
    J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanocarriers protecting toward an intestinal pre-uptake metabolism.
    Suchaoin W; Bernkop-Schnürch A
    Nanomedicine (Lond); 2017 Feb; 12(3):255-269. PubMed ID: 28093952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrophobic ion-pairs and lipid-based nanocarrier systems: The perfect match for delivery of BCS class 3 drugs.
    Phan TNQ; Shahzadi I; Bernkop-Schnürch A
    J Control Release; 2019 Jun; 304():146-155. PubMed ID: 31075345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving oral absorption via drug-loaded nanocarriers: absorption mechanisms, intestinal models and rational fabrication.
    Shahbazi MA; Santos HA
    Curr Drug Metab; 2013 Jan; 14(1):28-56. PubMed ID: 22497568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymeric micelles for oral drug delivery.
    Gaucher G; Satturwar P; Jones MC; Furtos A; Leroux JC
    Eur J Pharm Biopharm; 2010 Oct; 76(2):147-58. PubMed ID: 20600891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle.
    Harde H; Das M; Jain S
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1407-24. PubMed ID: 21831007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porous starch based self-assembled nano-delivery system improves the oral absorption of lipophilic drug.
    Zhang Z; Huang J; Jiang S; Liu Z; Gu W; Yu H; Li Y
    Int J Pharm; 2013 Feb; 444(1-2):162-8. PubMed ID: 23340325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration.
    Singh G; Pai RS
    J Pharm Pharmacol; 2014 Aug; 66(8):1062-76. PubMed ID: 24779896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.
    Wang XQ; Zhang Q
    Eur J Pharm Biopharm; 2012 Oct; 82(2):219-29. PubMed ID: 22885229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
    Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
    Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral delivery of proteins by biodegradable nanoparticles.
    Bakhru SH; Furtado S; Morello AP; Mathiowitz E
    Adv Drug Deliv Rev; 2013 Jun; 65(6):811-21. PubMed ID: 23608641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
    Banerjee S; Pillai J
    Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
    [No Abstract]   [Full Text] [Related]  

  • 15. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
    Hunter AC; Elsom J; Wibroe PP; Moghimi SM
    Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.
    Date AA; Hanes J; Ensign LM
    J Control Release; 2016 Oct; 240():504-526. PubMed ID: 27292178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiomers for oral delivery of hydrophilic macromolecular drugs.
    Bernkop-Schnürch A; Hoffer MH; Kafedjiiski K
    Expert Opin Drug Deliv; 2004 Nov; 1(1):87-98. PubMed ID: 16296722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of drug safety by the use of lipid-based nanocarriers.
    Lim SB; Banerjee A; Önyüksel H
    J Control Release; 2012 Oct; 163(1):34-45. PubMed ID: 22698939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for improving mucosal drug delivery.
    Laffleur F; Bernkop-Schnürch A
    Nanomedicine (Lond); 2013 Dec; 8(12):2061-75. PubMed ID: 24279493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
    Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
    Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.